Clinical Trial Update: Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1/2 studies measuring anti‑androgen response in androgen-insensitive prostate cancer using Fluorine-18 flu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fluorine-18 Fluorocholine (Fluorocholine F-18)

Snippet

Sponsor: Queen's Medical Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-11-19